Correlation Between Biocardia and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biocardia and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biocardia and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biocardia and BioNTech SE, you can compare the effects of market volatilities on Biocardia and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biocardia with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biocardia and BioNTech.

Diversification Opportunities for Biocardia and BioNTech

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biocardia and BioNTech is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Biocardia and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Biocardia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biocardia are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Biocardia i.e., Biocardia and BioNTech go up and down completely randomly.

Pair Corralation between Biocardia and BioNTech

Given the investment horizon of 90 days Biocardia is expected to under-perform the BioNTech. In addition to that, Biocardia is 1.74 times more volatile than BioNTech SE. It trades about -0.18 of its total potential returns per unit of risk. BioNTech SE is currently generating about -0.1 per unit of volatility. If you would invest  12,076  in BioNTech SE on September 25, 2024 and sell it today you would lose (663.00) from holding BioNTech SE or give up 5.49% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biocardia  vs.  BioNTech SE

 Performance 
       Timeline  
Biocardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biocardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
BioNTech SE 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Biocardia and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biocardia and BioNTech

The main advantage of trading using opposite Biocardia and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biocardia position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind Biocardia and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance